SEC Form 4 · accession 0000939798-17-000102
GT Biopharma, Inc. · GTBP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Tony Cataldo
Officer — Executive Chairman · Director · 10% Owner
Period of report
Sep 1, 2017
Accepted (ET)
Dec 1, 2017 · 7:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000109657
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| common stock | Sep 1, 2017 | A | 5,129,660 | $0.00 | A | 5,143,029 | D | |
| common stock | Nov 2, 2017 | G | 200,000 | $0.00 | D | 4,943,029 | D | |
| common stock | Nov 2, 2017 | G | 100,000 | $0.00 | D | 4,843,029 | D | |
| common stock | Nov 2, 2017 | G | 3,000,000 | $0.00 | D | 1,843,029 | D |
Table II — derivative securities
No Table II lines on this filing.